GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Teleflex Inc (FRA:TBH) » Definitions » EV-to-EBITDA

Teleflex (FRA:TBH) EV-to-EBITDA : 17.36 (As of May. 05, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Teleflex EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Teleflex's enterprise value is €10,427 Mil. Teleflex's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €601 Mil. Therefore, Teleflex's EV-to-EBITDA for today is 17.36.

The historical rank and industry rank for Teleflex's EV-to-EBITDA or its related term are showing as below:

FRA:TBH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.2   Med: 20.07   Max: 38.51
Current: 17.25

During the past 13 years, the highest EV-to-EBITDA of Teleflex was 38.51. The lowest was 12.20. And the median was 20.07.

FRA:TBH's EV-to-EBITDA is ranked better than
54.34% of 484 companies
in the Medical Devices & Instruments industry
Industry Median: 16.065 vs FRA:TBH: 17.25

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), Teleflex's stock price is €183.00. Teleflex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €5.785. Therefore, Teleflex's PE Ratio for today is 31.63.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Teleflex EV-to-EBITDA Historical Data

The historical data trend for Teleflex's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teleflex EV-to-EBITDA Chart

Teleflex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.21 32.85 20.22 18.14 17.65

Teleflex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.97 16.88 13.13 17.65 18.93

Competitive Comparison of Teleflex's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Teleflex's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teleflex's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Teleflex's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Teleflex's EV-to-EBITDA falls into.



Teleflex EV-to-EBITDA Calculation

Teleflex's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=10427.008/600.689
=17.36

Teleflex's current Enterprise Value is €10,427 Mil.
Teleflex's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €601 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Teleflex  (FRA:TBH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Teleflex's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=183.00/5.785
=31.63

Teleflex's share price for today is €183.00.
Teleflex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.785.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Teleflex EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Teleflex's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Teleflex (FRA:TBH) Business Description

Traded in Other Exchanges
Address
550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2022 sales), interventional (16%), anesthesia (14%), surgical (14%), interventional urology (12%), original-equipment manufacturing (10%), and all other (10%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Teleflex (FRA:TBH) Headlines

No Headlines